Stay updated on ARCHES: Enzalutamide in Metastatic Prostate Cancer Clinical Trial
Sign up to get notified when there's something new on the ARCHES: Enzalutamide in Metastatic Prostate Cancer Clinical Trial page.

Latest updates to the ARCHES: Enzalutamide in Metastatic Prostate Cancer Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe study history now reflects that recruitment has ended, and the version history shows a new revision entry (v3.6.0) with the previous revision (v3.5.5) removed.SummaryDifference0.2%

- Check20 days agoChange DetectedThe page footer revision label was updated from v3.5.4 to v3.5.5, indicating a newer version of the page rendering.SummaryDifference0.0%

- Check42 days agoChange DetectedThe study's revision history now shows Revision: v3.5.4 replacing Revision: v3.5.3, indicating an administrative update to the record. This change does not alter the study data, eligibility, or results.SummaryDifference0.0%

- Check56 days agoChange DetectedThe Record History now shows a new version tag (Revision: v3.5.3) replacing the previous v3.5.2. This indicates an update to the page history metadata rather than changes to the study content.SummaryDifference0.0%

- Check70 days agoChange DetectedAdded Revision: v3.5.2 and removed Revision: v3.5.0 in the page history.SummaryDifference0.0%

- Check92 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0 in the page footer.SummaryDifference0.0%

Stay in the know with updates to ARCHES: Enzalutamide in Metastatic Prostate Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ARCHES: Enzalutamide in Metastatic Prostate Cancer Clinical Trial page.